Patient presents with a personal history of endometrial cancer (endometrial carcinoma, uterine cancer).  Initial diagnosis date was [Date of Diagnosis].  The primary site was [Location of Primary Tumor, e.g., endometrium, uterus] and the histologic type was [Histology, e.g., endometrioid adenocarcinoma, serous carcinoma].  The stage at diagnosis was [Stage, e.g., IA, IIB] according to the [Staging System, e.g., FIGO, AJCC] staging system.  Initial treatment consisted of [Treatment details, e.g., total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, followed by adjuvant chemotherapy with carboplatin and paclitaxel].  Patient reports [Symptoms, e.g., being asymptomatic, experiencing vaginal bleeding, pelvic pain].  Current surveillance includes [Surveillance plan, e.g., physical examination, CA-125 levels, pelvic ultrasound] every [Frequency, e.g., 3 months, 6 months].  Assessment includes ongoing monitoring for recurrence of endometrial cancer.  Plan includes continued surveillance per established guidelines and management of any recurrent or persistent symptoms.  Differential diagnoses at the time of initial diagnosis included [Differential Diagnoses, e.g., atypical endometrial hyperplasia, uterine fibroids, endometrial polyps].  Relevant medical history includes [Relevant medical history, e.g., history of obesity, hypertension, diabetes, use of tamoxifen]. Family history is significant for [Family history, e.g., breast cancer, ovarian cancer, Lynch syndrome].  Patient education provided regarding signs and symptoms of recurrence, importance of follow-up appointments, and healthy lifestyle modifications.